The stock of Annovis Bio Inc (ANVS) has gone down by -20.86% for the week, with a -34.13% drop in the past month and a -48.05% drop in the past quarter. The volatility ratio for the week is 8.63%, and the volatility levels for the past 30 days are 8.95% for ANVS. The simple moving average for the past 20 days is -26.19% for ANVS’s stock, with a -48.31% simple moving average for the past 200 days.
Is It Worth Investing in Annovis Bio Inc (NYSE: ANVS) Right Now?
Company’s 36-month beta value is 1.66.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ANVS is 10.98M, and currently, short sellers hold a 11.95% ratio of that floaft. The average trading volume of ANVS on December 20, 2024 was 274.56K shares.
ANVS) stock’s latest price update
The stock of Annovis Bio Inc (NYSE: ANVS) has decreased by -6.58 when compared to last closing price of 4.71.Despite this, the company has seen a loss of -20.86% in its stock price over the last five trading days. globenewswire.com reported 2024-12-05 that LOS ANGELES, Dec. 05, 2024 (GLOBE NEWSWIRE) — via IBN — InvestorBrandNetwork, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce Annovis Bio’s (NYSE: ANVS) recent feature on Today’s Marketplace (TMP) as part of its commitment to amplifying industry leaders’ voices through targeted distribution channels.
Analysts’ Opinion of ANVS
Many brokerage firms have already submitted their reports for ANVS stocks, with Maxim Group repeating the rating for ANVS by listing it as a “Buy.” The predicted price for ANVS in the upcoming period, according to Maxim Group is $25 based on the research report published on October 25, 2024 of the current year 2024.
Canaccord Genuity, on the other hand, stated in their research note that they expect to see ANVS reach a price target of $36. The rating they have provided for ANVS stocks is “Buy” according to the report published on December 29th, 2023.
Maxim Group gave a rating of “Buy” to ANVS, setting the target price at $150 in the report published on July 07th of the previous year.
ANVS Trading at -40.78% from the 50-Day Moving Average
After a stumble in the market that brought ANVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.44% of loss for the given period.
Volatility was left at 8.95%, however, over the last 30 days, the volatility rate increased by 8.63%, as shares sank -32.72% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.34% lower at present.
During the last 5 trading sessions, ANVS fell by -20.86%, which changed the moving average for the period of 200-days by -52.94% in comparison to the 20-day moving average, which settled at $5.96. In addition, Annovis Bio Inc saw -76.47% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ANVS
The total capital return value is set at -3.39. Equity return is now at value -596.70, with -333.05 for asset returns.
Currently, EBITDA for the company is -45.04 million with net debt to EBITDA at 0.42. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.66.
Conclusion
In a nutshell, Annovis Bio Inc (ANVS) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
